Protagenic Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 76.43 | -100% | -1.76 | -100% |
| P/S |
|
0 | 8.3 | -100% |
|
|
| P/BV |
|
0.9949 | 9.3 | -89.3% |
|
|
| P/FCF |
|
-2.1 | 33.18 | -106.34% |
|
|
| Ev/Ebitda |
|
-0.5249 | 121.84 | -100.43% |
|
|
| Ev/S |
|
0 | 8.06 | -100% |
|
|
| Ev/FCF |
|
-0.6128 | 43.81 | -101.4% |
|
|
| E/P |
|
-0.6173 | 0.0039 | -15873.46% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 23.09 | -100% | -168.5 | -100% |
| ROE |
|
-136.32 | 16.8 | -911.53% |
|
|
| ROA |
|
-115.66 | 9.13 | -1367.51% |
|
|
| ROIC |
|
-100.07 | 13.26 | -854.54% |
|
|
| ROS |
|
0 | 13.05 | -100% |
|
|
| ROCE |
|
-123.41 | 18.05 | -783.86% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0765 | 9.17 | -100.83% | -0.0955 | -19.96% |
| Nеt Debt/Ebitda |
|
0.2863 | 6.82 | -95.8% |
|
|
| Debt/Ratio |
|
0.0796 | 0.2335 | -65.93% |
|
|
| Debt/Equity |
|
0.043 | 5.19 | -99.17% |
|
|
| Debt/Net Income |
|
-0.0688 | 2.66 | -102.58% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.6658 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
1 | 3.11 | -67.84% | ||
| DSI |
|
0.5 | 0.5058 | -1.15% |
|
|
| Average dividend growth |
|
0 | -124.47 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.7385 | -100% |
|
|
| Average percentage for payments |
|
0 | 36.5 | -100% |
|
|
| Difference from average difference in sector |
|
-0.6658 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-99.77 | 44.58 | -323.8% | ||
| Growth impulse Ebitda in 5 years |
|
115.98 | -109.1 | -206.31% | ||
| Growth impulse Net Income in 5 years |
|
150.02 | 71.98 | 108.42% | ||
| Growth impulse FCF in 5 years |
|
689.68 | 68.34 | 909.19% | ||
| Growth impulse EPS in 5 years |
|
577.04 | -6.33 | -9215.96% |
IP Score
4.51/10
